Sanofi forms drug dis­cov­ery pact with French start­up Aqemia en route to ‘AI at scale’ am­bi­tion

1 hour ago
Startups
Deals

Al­to Neu­ro­science un­veils ef­fi­ca­cy sig­nal from PhI­Ia MDD tri­al with ma­chine learn­ing-iden­ti­fied bio­mark­er

10 hours ago
R&D

23andMe said hack­ers ac­cessed over five mil­lion mem­bers’ an­ces­try in­fo

10 hours ago
Health Tech

Roche's BTK in­hibitor put on par­tial hold over con­cerns about po­ten­tial liv­er in­jury

11 hours ago
Pharma
FDA+

En­do hits the pool hall with Pey­ronie’s dis­ease pa­tients for lat­est cam­paign

11 hours ago
Marketing

Fu­ji­film makes $200M man­u­fac­tur­ing in­vest­ment while No­var­tis pours $80M+ in­to Chi­na fa­cil­i­ty

12 hours ago
Pharma
Manufacturing

Supreme Court weighs in on Pur­due Phar­ma's bank­rupt­cy, with an eye to­ward opi­oid vic­tims

12 hours ago
Law

Health in­sur­ance mem­bers stand to lose out if Cigna and Hu­mana fi­nal­ize a megamerg­er, ex­perts say

13 hours ago
Health Tech

House com­mit­tee in­ves­ti­gates FDA’s han­dling of com­mon nasal de­con­ges­tant as ef­fi­ca­cy ques­tions loom

15 hours ago
Pharma
FDA+

Wet AMD biotech stock soars over 200% as lead as­set match­es Re­gen­eron’s Eylea in PhII test

15 hours ago
R&D

Ideaya part­ners with Gilead; Lil­ly ex­tends of­fer for Point; The­seus lets go of CEO, CMO

15 hours ago
News Briefing

At­se­na touts one-year da­ta for con­gen­i­tal eye dis­ease ther­a­py as it seeks part­ner for piv­otal study

16 hours ago
R&D
Cell/Gene Tx

Ab­bisko signs $70M up­front deal with Mer­ck KGaA for PhI­II can­cer drug

17 hours ago
Deals
China

WuXi Bi­o­log­ics’ stock slides 24% as man­u­fac­tur­ing busi­ness slows amid biotech down­turn

20 hours ago
Manufacturing

No­var­tis un­veils new brand iden­ti­ty af­ter San­doz spin­off

20 hours ago
Pharma
Marketing

UCSF sci­en­tists aim to un­rav­el autism with brain organoids and AI

20 hours ago
R&D
AI

Seis­mic rais­es $121M to en­ter im­munol­o­gy space spot­light­ed by ar­genx, Im­muno­vant and oth­ers

20 hours ago
Financing
R&D

As­traZeneca inks $247M deal with gen­er­a­tive AI shop Ab­sci to de­vel­op an­ti­body drug for can­cer

20 hours ago
Deals
AI

FDA ap­proves Lil­ly’s BTK in­hibitor Jaypir­ca for two more blood can­cers

21 hours ago
Pharma
FDA+

Up­dat­ed: Roche buys obe­si­ty and di­a­betes biotech Car­mot Ther­a­peu­tics in $2.7B merg­er deal

22 hours ago
Deals

FDA’s CAR-T safe­ty probe; Ab­b­Vie’s $10B ADC wa­ger; Pfiz­er’s GLP-1 set­back; Ace­lyrin’s CRO dra­ma; and more

2 days ago
Weekly

Sam­sung Bioepis strikes deal for Ste­lara biosim­i­lar, but launch like­ly won't come in time for an IRA ex­emp­tion

3 days ago
Pharma
FDA+

Apel­lis' eye dis­ease drug gets safe­ty la­bel up­date for rare in­flam­ma­tion side ef­fect

3 days ago
R&D
FDA+

Pfiz­er, Idor­sia and Ab­b­Vie drug brands lead the way in phar­ma dig­i­tal mar­ket­ing — study

3 days ago
Marketing
1234 Next page Last page
A service from the Financial Times